Horizon Therapeutics Common
|
12.5 |
$684M |
|
6.5M |
105.21 |
United Therapeutics Corp Common
(UTHR)
|
9.9 |
$544M |
|
3.0M |
179.41 |
Apellis Pharmaceuticals Common
(APLS)
|
8.8 |
$480M |
|
9.5M |
50.81 |
Mirati Therapeutics Common
|
8.0 |
$438M |
|
5.3M |
82.22 |
Argenx Se Sponsored ADR
(ARGX)
|
7.2 |
$396M |
|
1.3M |
315.31 |
Spdr Series Trust - S&p Biotech Etf
(XBI)
|
5.0 |
$274M |
|
3.1M |
89.88 |
Ascendis Pharma Sponsored ADR
(ASND)
|
4.7 |
$258M |
|
2.2M |
117.36 |
Sarepta Therapeutics Common
(SRPT)
|
4.5 |
$245M |
|
3.1M |
78.12 |
Biomarin Pharmaceutical Common
(BMRN)
|
4.3 |
$234M |
|
3.0M |
77.10 |
Alnylam Pharmaceuticals Common
(ALNY)
|
3.9 |
$212M |
|
1.3M |
163.29 |
Amicus Therapeutics Common
(FOLD)
|
3.5 |
$194M |
|
21M |
9.47 |
Seagen Common
|
3.5 |
$189M |
|
1.3M |
144.05 |
Xenon Pharmaceuticals Common
(XENE)
|
2.8 |
$152M |
|
5.0M |
30.57 |
Iovance Biotherapeutics Common
(IOVA)
|
2.8 |
$152M |
|
9.1M |
16.65 |
Madrigal Pharmaceuticals Common
(MDGL)
|
2.6 |
$140M |
|
1.4M |
98.12 |
Iveric Bio Common
|
2.2 |
$122M |
|
7.3M |
16.83 |
Kura Oncology Common
(KURA)
|
1.4 |
$77M |
|
4.8M |
16.08 |
Krystal Biotech Common
(KRYS)
|
1.2 |
$67M |
|
1.0M |
66.54 |
Acadia Pharmaceuticals Common
(ACAD)
|
1.0 |
$55M |
|
2.3M |
24.22 |
Monte Rosa Therapeutics Common
(GLUE)
|
0.8 |
$46M |
|
3.3M |
14.02 |
Pmv Pharmaceuticals Common
(PMVP)
|
0.8 |
$46M |
|
2.2M |
20.82 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.7 |
$39M |
|
2.2M |
17.38 |
Design Therapeutics Common
(DSGN)
|
0.7 |
$36M |
|
2.2M |
16.15 |
Kymera Therapeutics Common
(KYMR)
|
0.6 |
$35M |
|
817k |
42.32 |
Mannkind Corp Common
(MNKD)
|
0.6 |
$32M |
|
8.8M |
3.68 |
Cymabay Therapeutics Common
|
0.6 |
$32M |
|
10M |
3.11 |
Aadi Biosciences Common
(AADI)
|
0.6 |
$31M |
|
1.8M |
16.97 |
Biocryst Pharmaceuticlas Common
(BCRX)
|
0.6 |
$31M |
|
1.9M |
16.26 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.5 |
$30M |
|
3.2M |
9.35 |
Mersana Therapeutics Common
(MRSN)
|
0.5 |
$27M |
|
6.8M |
3.99 |
Avidity Biosciences Common
(RNA)
|
0.4 |
$24M |
|
1.3M |
18.47 |
Praxis Precision Medicines Common
|
0.4 |
$22M |
|
2.2M |
10.21 |
Dice Therapeutics Common
|
0.4 |
$21M |
|
1.1M |
19.13 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.4 |
$20M |
|
6.0M |
3.29 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.3 |
$17M |
|
230k |
72.62 |
Nuvalent Common
(NUVL)
|
0.3 |
$15M |
|
1.0M |
13.89 |
Tango Therapeutics Common
(TNGX)
|
0.2 |
$12M |
|
1.6M |
7.58 |
Avadel Pharmaceuticals Sponsored ADR
|
0.2 |
$11M |
|
1.7M |
6.83 |
Io Biotech Common
(IOBT)
|
0.2 |
$9.6M |
|
2.1M |
4.66 |
Adverum Biotechnologies Common
|
0.2 |
$9.1M |
|
7.0M |
1.31 |
Applied Molecular Trans Common
|
0.1 |
$7.7M |
|
1.0M |
7.52 |
Fennec Pharmaceuticals Common
(FENC)
|
0.1 |
$6.7M |
|
1.2M |
5.60 |
Genocea Biosciences Common
(GNCAQ)
|
0.1 |
$6.4M |
|
5.1M |
1.25 |